Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat in Conservatively Managed Intracranial Hemorrhage
NCT07701512Phase 2Recruiting
- Sponsor
- Tanta University
- Start
- Nov 2025
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
A Phase 2 trial of febuxostat in intracranial hemorrhage (ICH), sponsored by Tanta University. Started Nov 2025; status: recruiting.
02
Drugs
febuxostat
03
Conditions
intracranial hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07701512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07701512.